Reporting Needed for Chemical Abortion

A new study reveals “glaring deficiencies” in the way complications are being reported after women undergo a chemical abortion pill procedure.  Over 30 board certified physicians spent three years analyzing the data on complications and deaths.  The study, published in Issues in Law and Medicine, found 60% of women experiencing complications went to local emergency rooms instead of the abortion facilities, which hugely affects accurate reporting.  These findings come at a time the abortion industry is seeking telemedicine and mail order access to the dangerous abortion pill, which would devastate accurate reporting.  The FDA reporting system already significantly underestimates complications and deaths.  We need more guidelines, not fewer, to protect women.